Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Cardiac Marker Testing Market to Reach $3.50 Billion by 2021 - Growing Funding from Public-Private Organizations for Research - Research and Markets

Research and Markets
Posted on: 23 Nov 16

Research and Markets has announced the addition of the "Cardiac Marker Testing Market - Global Forecast to 2021" report to their offering.

The global cardiac marker testing market is estimated to grow at a CAGR of 8.8% from 2016 to 2021 to reach USD 3.50 billion by 2021.

Factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker testing market. On the other hand, technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are the key factors limiting the growth of the global cardiac marker testing market.

Geographically, North America commands the largest share of the global cardiac marker testing market in 2016, followed by Europe. The cardiac marker testing market in North America is primarily driven by the increasing incidence of cardiovascular diseases, growing public-private investments, NIH support towards the development of novel cardiac biomarkers, and rising geriatric population.

The cardiac marker testing market is highly competitive owing to the presence of a number of large and small firms. With improving industry standards, the global market has been witnessing several product innovations. New product launches was the key growth strategy adopted by market players to strengthen their market positions.

Companies Mentioned:

  • Abbott Laboratories
  • Alere Inc.
  • Biomérieux SA
  • Danaher Corporation
  • Guangzhou Wondfo Biotech Co., Ltd.
  • LSI Medience Corporation
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Roche Diagnostics Limited
  • Siemens AG

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Cardiac Marker Testing Market, By Type

8 Cardiac Marker Testing Market, By Product

9 Cardiac Marker Testing Market, By Disease

10 Cardiac Marker Testing Market, By Type of Testing

11 Cardiac Marker Testing Market, By Region

12 Competitive Landscape

13 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/ltqhkr/cardiac_marker

View source version on businesswire.com: http://www.businesswire.com/news/home/20161123005293/en/

Business Wire
www.businesswire.com

Last updated on: 23/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.